Anaplastic Thyroid Carcinoma Following Radioactive Iodine Therapy for Graves' Disease
Radioactive iodine (RAI) therapy has been used as a treatment option for Graves' disease, and it has been widely accepted to be safe. On the other hand, some evidence suggests that RAI therapy is possibly associated with a small increased risk of thyroid cancer. Herein, we report a rare case of...
Main Authors: | Sun Hwa Kim, Hee Young Kim, Kwang Yoon Jung, Dong Seop Choi, Sin Gon Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Endocrine Society
2013-03-01
|
Series: | Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-28-61.pdf |
Similar Items
-
Association between radioactive iodine uptake and neutropenia in untreated Graves’ disease
by: Qian Yang, et al.
Published: (2023-01-01) -
Thyroid Receptor Antibody and the Development of Graves’ Orbitopathy: Clinical Experience of using Radioiodine Ablation in the Management of Graves’ Orbitopathy in post-iodine ablation hypothyroid patient
by: Edelyn Christina, et al.
Published: (2023-06-01) -
Effect of liver dysfunction on outcome of radioactive iodine therapy for Graves’ disease
by: Yuyang Ze, et al.
Published: (2022-12-01) -
131I therapy for hyperthyroidism and consequent appearing of anaplastic carcinoma of the thyroid: simple case-report or real pathophysiologic link?
by: G. Scanelli, et al.
Published: (2013-05-01) -
TPO antibody status prior to first radioactive iodine therapy as a predictive parameter for hypothyroidism in Graves’ disease
by: Sébastien Verdickt, et al.
Published: (2023-01-01)